Abstract:Rhodotorula mucilaginosa, an environmental yeast widely used in industry and agriculture, is also an opportunistic pathogen resistant to multi-antifungals. During the national surveillance in China, R. mucilaginosa has been documented from various hospitals and regions. At present, the molecular epidemiology of invasive infections caused by R. mucilaginosa and their resistance profiles to antifungals were unknown. Here we collected 49 strains from four hospitals located in different geographic regions from 2009 to 2019 in China, determined their genotypes using different molecular markers and quantified susceptibilities to various antifungals. Sequencing of ITS and D1/D2 regions in rDNA indicated that 73.5% (36/49) of clinical strains belong to same sequence type (rDNA type 2). Microsatellite (MT) genotyping with 15 (recently developed) tandem repeat loci identified 5 epidemic MT types, which accounted for 44.9% (22/49) of clinical strains, as well as 27 sporadic MT types. Microsatellite data indicated that the presence of an epidemic cluster including 35 strains (71.4%) repeatedly isolated in four hospitals for eight years. Single nucleotide variants (SNVs) from the whole genome sequence data also supported the clustering of these epidemic strains due to low pairwise distance. In addition, phylogenetic analysis of SNVs from these clinical strains, together with environmental and animal strains showed that the closely related epidemic cluster strains may be opportunistic, zoonotic pathogens. Also, molecular data indicated a possible clonal transmission of pan echinocandins-azoles-5-flucytosine resistant R. mucilaginosa strains in hospital H01. Our study demonstrated that R. mucilaginosa is a multi-drug resistant pathogen with the ability to cause nosocomial infection.

Fungemia Due to Rhodotorula Mucilaginosa:Clinical and Experimental Study

Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: an Update from the CHIF-NET Study

Fatal Gastrointestinal Mucormycosis in an Immunocompetent Patient : a Case Report and Review of the Literature

Rhodotorula mucilaginosa Fungemia, a Rare Opportunistic Infection without Central Venous Catheter Implantation, Successfully Treated by Liposomal Amphotericin B

Fungemia due to Rhodotorula mucilaginosa after allogeneic hematopoietic stem cell transplantation

Successful treatment of Candida tropicalis osteomyelitis with Micafungin in a leukemia patient

Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital

Clinical and microbiological characteristics of Rhodotorula mucilaginosa infections in a tertiary-Care facility

Fungemia: A Retrospective Clinical Analysis of 17 Patients

Persistence of an epidemic cluster of Rhodotorula mucilaginosa in multiple geographic regions in China and the emergence of a 5-flucytosine resistant clone

The Epidemiology and Clinical Characteristics of Fungemia in a Tertiary Hospital in Southern China: A 6-Year Retrospective Study

Morphology and Molecular Analysis of Moesziomyces antarcticus Isolated From the Blood Samples of a Chinese Patient

Rhodotorula mucilaginosa Fungemia in an Infected Biloma Patient Following a Traumatic Liver Injury

Identification and susceptibility of Rhizomucor spp. isolated from patients with cutaneous zygomycosis in China.

A Case of Primary Cutaneous Mucormycosis Caused by Mucor Irregularis in Henan Province

Mucormycosis in Renal Transplant Recipients: Review of 174 Reported Cases.

Carriage characteristics and drug susceptibility profile of isolated and identified oral Rhodotorula spp

Significant Morbidity and Mortality Attributable to Rothia Mucilaginosa Infections in Children with Hematological Malignancies or Following Hematopoietic Stem Cell Transplantation

Primary Cutaneous Mucormycosis Caused by Rhizomucor variabilis in an Immunocompetent Patient

Cutaneous Mucormycosis Caused by Rhizopus Microsporus in an Immunocompetent Patient

First Case of Fungemia Caused by a Rare and Pan-Echinocandin Resistant Yeast Sporopachydermia Lactativora in China